학술논문
Rilpivirine plus cobicistat-boosted darunavir as a two-drug switch regimen in HIV-infected, virologically suppressed subjects on steady standard three-drug therapy: a randomized, controlled, non-inferiority trial (PROBE 2).
Document Type
Journal Article
Author
Source
Subject
*HIV infections
*ANTI-HIV agents
*RESEARCH
*VIRAL load
*PURINES
*RESEARCH methodology
*MEDICAL cooperation
*EVALUATION research
*TREATMENT effectiveness
*COMPARATIVE studies
*RANDOMIZED controlled trials
*DRUGS
*HIV
*
*
*
*
*
*
*
*
*
*
*
*
Language
ISSN
0305-7453
Abstract